CL2009001019A1 - Compuestos derivados de pirrolo[1,2-c]imidazol-3-ona, imidazo[indol-3-ona e imidazo[1,5-a]piridin-3-ona sustituidos; procedeimiento de preparacion; su composicion farmaceutica; utiles en el tratamiento de la diabetes, obesidad, trastornos de ingesta d comida o dislepidemia. - Google Patents
Compuestos derivados de pirrolo[1,2-c]imidazol-3-ona, imidazo[indol-3-ona e imidazo[1,5-a]piridin-3-ona sustituidos; procedeimiento de preparacion; su composicion farmaceutica; utiles en el tratamiento de la diabetes, obesidad, trastornos de ingesta d comida o dislepidemia.Info
- Publication number
- CL2009001019A1 CL2009001019A1 CL2009001019A CL2009001019A CL2009001019A1 CL 2009001019 A1 CL2009001019 A1 CL 2009001019A1 CL 2009001019 A CL2009001019 A CL 2009001019A CL 2009001019 A CL2009001019 A CL 2009001019A CL 2009001019 A1 CL2009001019 A1 CL 2009001019A1
- Authority
- CL
- Chile
- Prior art keywords
- imidazo
- obesity
- diabetes
- useful
- treatment
- Prior art date
Links
- 208000030814 Eating disease Diseases 0.000 title abstract 2
- 208000019454 Feeding and Eating disease Diseases 0.000 title abstract 2
- 208000008589 Obesity Diseases 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 206010012601 diabetes mellitus Diseases 0.000 title abstract 2
- 235000014632 disordered eating Nutrition 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 235000020824 obesity Nutrition 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 238000011282 treatment Methods 0.000 title abstract 2
- DYBPHASIZGHLDG-UHFFFAOYSA-N pyrrolo[1,2-c]imidazol-3-one Chemical compound C1=CN2C(=O)N=CC2=C1 DYBPHASIZGHLDG-UHFFFAOYSA-N 0.000 title 1
- 208000032928 Dyslipidaemia Diseases 0.000 abstract 1
- YAMHXTCMCPHKLN-UHFFFAOYSA-N imidazolidin-2-one Chemical compound O=C1NCCN1 YAMHXTCMCPHKLN-UHFFFAOYSA-N 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
Abstract
Compuestos derivados de imidazolidinona inhibidores de 11b-hsd1, procedimiento de preparación, composición farmacéutica, útil para el tratamiento o la profilaxis de la diabetes, la obesidad, trastornos de la ingestión de comida o las dislipidemias.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08155430 | 2008-04-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2009001019A1 true CL2009001019A1 (es) | 2011-01-07 |
Family
ID=40790778
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2009001019A CL2009001019A1 (es) | 2008-04-30 | 2009-04-29 | Compuestos derivados de pirrolo[1,2-c]imidazol-3-ona, imidazo[indol-3-ona e imidazo[1,5-a]piridin-3-ona sustituidos; procedeimiento de preparacion; su composicion farmaceutica; utiles en el tratamiento de la diabetes, obesidad, trastornos de ingesta d comida o dislepidemia. |
Country Status (18)
Country | Link |
---|---|
US (1) | US8124636B2 (es) |
EP (1) | EP2280970B1 (es) |
JP (1) | JP2011520790A (es) |
KR (1) | KR20110008198A (es) |
CN (1) | CN102015706B (es) |
AR (1) | AR071512A1 (es) |
AU (1) | AU2009242248A1 (es) |
BR (1) | BRPI0910549A2 (es) |
CA (1) | CA2722487A1 (es) |
CL (1) | CL2009001019A1 (es) |
ES (1) | ES2445094T3 (es) |
IL (1) | IL208626A0 (es) |
MX (1) | MX2010011642A (es) |
PE (1) | PE20091811A1 (es) |
RU (1) | RU2538986C2 (es) |
TW (1) | TW200946535A (es) |
WO (1) | WO2009132986A1 (es) |
ZA (1) | ZA201007431B (es) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011107494A1 (de) | 2010-03-03 | 2011-09-09 | Sanofi | Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung |
US8530413B2 (en) | 2010-06-21 | 2013-09-10 | Sanofi | Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments |
TW201215387A (en) | 2010-07-05 | 2012-04-16 | Sanofi Aventis | Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament |
TW201215388A (en) | 2010-07-05 | 2012-04-16 | Sanofi Sa | (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments |
TW201221505A (en) | 2010-07-05 | 2012-06-01 | Sanofi Sa | Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament |
SG186275A1 (en) | 2010-07-06 | 2013-01-30 | Astrazeneca Ab | Therapeutic agents 976 |
US8497288B2 (en) * | 2011-05-09 | 2013-07-30 | Hoffmann-La Roche Inc. | Hexahydropyrroloimidazolone compounds |
WO2013037390A1 (en) | 2011-09-12 | 2013-03-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
EP2760862B1 (en) | 2011-09-27 | 2015-10-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
EP3235813A1 (en) | 2016-04-19 | 2017-10-25 | Cidqo 2012, S.L. | Aza-tetra-cyclo derivatives |
US20230040182A1 (en) * | 2019-10-07 | 2023-02-09 | D. E. Shaw Research, Llc | ARYL HETEROBICYCLIC COMPOUNDS AS Kv1.3 POTASSIUM SHAKER CHANNEL BLOCKERS |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3809390A1 (de) * | 1988-03-16 | 1989-09-28 | Schering Ag | Perhydro-imidazopyridine und -pyrroloimidazole, verfahren zu ihrer herstellung und ihre verwendung als herbizide mittel |
ES2292262T3 (es) * | 1998-12-24 | 2008-03-01 | Astellas Pharma Inc. | Compuestos de imidazol y su uso medicinal. |
EP1404325A2 (en) * | 2001-05-29 | 2004-04-07 | Guilford Pharmaceuticals Inc. | Method for treating nerve injury caused by surgery |
TW200407324A (en) * | 2002-05-17 | 2004-05-16 | Bristol Myers Squibb Co | Bicyclic modulators of androgen receptor function |
EP1786774B1 (en) * | 2004-08-30 | 2009-10-14 | Janssen Pharmaceutica N.V. | Tricyclic lactam derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors |
WO2008007664A1 (fr) * | 2006-07-11 | 2008-01-17 | Takeda Pharmaceutical Company Limited | Composé hétérocyclique bicycique et son utilisation |
WO2008044656A1 (fr) * | 2006-10-06 | 2008-04-17 | Taisho Pharmaceutical Co., Ltd. | Dérivé d'imidazolidinone |
MX2009003939A (es) * | 2006-10-19 | 2009-05-11 | Hoffmann La Roche | Derivados de imidazolona e imidazolidinona como inhibidores de la 11-beta-hidroxiesteroide deshidrogenasa de tipo 1 para diabetes. |
-
2009
- 2009-04-16 US US12/424,587 patent/US8124636B2/en not_active Expired - Fee Related
- 2009-04-21 KR KR1020107024234A patent/KR20110008198A/ko not_active Application Discontinuation
- 2009-04-21 CA CA2722487A patent/CA2722487A1/en not_active Abandoned
- 2009-04-21 WO PCT/EP2009/054701 patent/WO2009132986A1/en active Application Filing
- 2009-04-21 AU AU2009242248A patent/AU2009242248A1/en not_active Abandoned
- 2009-04-21 MX MX2010011642A patent/MX2010011642A/es active IP Right Grant
- 2009-04-21 BR BRPI0910549A patent/BRPI0910549A2/pt not_active IP Right Cessation
- 2009-04-21 EP EP09738030.7A patent/EP2280970B1/en not_active Not-in-force
- 2009-04-21 ES ES09738030.7T patent/ES2445094T3/es active Active
- 2009-04-21 JP JP2011506654A patent/JP2011520790A/ja active Pending
- 2009-04-21 RU RU2010148534/04A patent/RU2538986C2/ru not_active IP Right Cessation
- 2009-04-21 CN CN200980115164.6A patent/CN102015706B/zh not_active Expired - Fee Related
- 2009-04-27 PE PE2009000571A patent/PE20091811A1/es not_active Application Discontinuation
- 2009-04-28 TW TW098114080A patent/TW200946535A/zh unknown
- 2009-04-28 AR ARP090101500A patent/AR071512A1/es not_active Application Discontinuation
- 2009-04-29 CL CL2009001019A patent/CL2009001019A1/es unknown
-
2010
- 2010-10-11 IL IL208626A patent/IL208626A0/en unknown
- 2010-10-18 ZA ZA2010/07431A patent/ZA201007431B/en unknown
Also Published As
Publication number | Publication date |
---|---|
RU2538986C2 (ru) | 2015-01-10 |
CN102015706A (zh) | 2011-04-13 |
US8124636B2 (en) | 2012-02-28 |
RU2010148534A (ru) | 2012-06-10 |
JP2011520790A (ja) | 2011-07-21 |
EP2280970A1 (en) | 2011-02-09 |
IL208626A0 (en) | 2010-12-30 |
AR071512A1 (es) | 2010-06-23 |
PE20091811A1 (es) | 2009-11-21 |
ES2445094T3 (es) | 2014-02-28 |
MX2010011642A (es) | 2010-11-25 |
BRPI0910549A2 (pt) | 2016-04-19 |
KR20110008198A (ko) | 2011-01-26 |
TW200946535A (en) | 2009-11-16 |
CN102015706B (zh) | 2014-07-16 |
AU2009242248A1 (en) | 2009-11-05 |
ZA201007431B (en) | 2013-03-27 |
WO2009132986A1 (en) | 2009-11-05 |
EP2280970B1 (en) | 2014-01-08 |
CA2722487A1 (en) | 2009-11-05 |
US20090275573A1 (en) | 2009-11-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2009001019A1 (es) | Compuestos derivados de pirrolo[1,2-c]imidazol-3-ona, imidazo[indol-3-ona e imidazo[1,5-a]piridin-3-ona sustituidos; procedeimiento de preparacion; su composicion farmaceutica; utiles en el tratamiento de la diabetes, obesidad, trastornos de ingesta d comida o dislepidemia. | |
DK2321321T3 (da) | Triazolo [4,5-d]pyramidinderivater og anvendelse deraf som purinreceptorantagonister | |
ECSP088906A (es) | PIRAZOLO 1,5-a PIRIMIDINAS | |
CL2012001329A1 (es) | Procedimiento de purificacion de {4,6-diamino-2-[1-(2-fluorobencil)-1h-pirazolo-[3,4-b]piridin-3-il] pirimidin-5-il} metilcarbamato de metilo; y el compuesto intermediario que se obtiene. | |
IL204693A0 (en) | Imidazo[1, 2 - a] pyrimidine derivatives for the treatment of diseases such as diabetes | |
WO2008121687A3 (en) | Imidazo[1,2-a]pyridine compounds as receptor tyrosine kinase inhibitors | |
UA95940C2 (uk) | Азаіндоли як інгібітори кіназ януса | |
UA100400C2 (uk) | Похідні спіроциклічних амідів | |
CR10458A (es) | Compuestos de triazolopirazina utiles para el tratamiento de enfermedades degenerativas e inflamatorias | |
CL2011001361A1 (es) | Compuestos derivados de n-(imidazo[1,2-a]pirazin-8-il)-1h-amina; composicion farmaceutica que los comprende; y su uso en el tratamiento de enfermedades mediadas por inhiibicion de actividad syk, tales como cancer, trastornos alergicos o inflamatorios. | |
TN2011000247A1 (en) | Organic compounds | |
CL2009000426A1 (es) | Compuestos derivados de carbociclil/heterociclil-piridin-2-il-urea, inhibidores de topoisomerasa iv bacteriana; composicion farmaceutica; y su uso para el tratamiento de infecciones bacterianas | |
ATE520668T1 (de) | Sigmarezeptor-inhibitoren | |
CL2008001122A1 (es) | Compuestos derivados de imidazo[1,2,3-ij]-1,8-naftiridin-4,9-diona; compuestos intermediarios; composicion farmaceutica; y uso en el tratamiento de infecciones bacterianas. | |
TN2011000245A1 (en) | Organic compounds | |
JO2903B1 (en) | Salts and crystalline forms of 2-methyl-2-[4-3-methyl-2-oxo-8-quinoline-3-yl-3-yl-2, 3-dihydro-imidazo [4,5-c] quinoline -1- YL) - phenyl - propionitrile | |
EA201000615A1 (ru) | Производные имидазо[1,2-а]пиридина, применимые в качестве ингибиторов апк (активиноподобной киназы) | |
MX2009013321A (es) | Derivados de espiro[piperidin-4,4'-tieno[3,2-c]pirano] y compuestos relacionados como inhibidores del receptor sigma para el tratamiento de psicosis. | |
NZ703111A (en) | Novel 3,5-disubstitued-3h-imidazo[4,5-b]pyridine and 3,5- disubstitued -3h-[1,2,3]triazolo[4,5-b] pyridine compounds as modulators of protein kinases | |
CL2012001027A1 (es) | Compuestos derivados de 7-(fenilamina)-5-oxo-1,2,3,5-tetrahidro-imidazo[1,2-a]piridina, 7-(fenilamina)5-oxo-2,3-dihidro-5h-tiazolo[3,2-a]piridina, 7-(fenulaminas)-5-oxo-2,3-dihidro-2hoxazolo[3,2-a]piridina: composicion farmaceutica; utiles en el tratamiento de enfermedades, trastornos o sindrome asociado con la inhibicion mek. | |
ES2340502T3 (es) | Compuestos de 1,4,8-triazaespiro(4,5)decan-2-ona sustituidos para el tratamiento de la obesidad. | |
WO2007095223A3 (en) | Pyrrolo(3,2-c) pyridines useful as inhibitors of protein kinases | |
NO20091489L (no) | Tiazolpyrazolopyridiner som CRF1 reseptorantagonister | |
CL2011000116A1 (es) | Compuestos derivados de imidazo[1,2-a]piridina; procedimiento de preparacion; composicion farmaceutica; compuestos intermediarios; y uso en el tratamiento del cancer. | |
CL2013001591A1 (es) | Compuestos derivados de triazolopiridina; inhibidores de pde10a; proceso de obtencion; composicion farmaceutica; y uso en el tratamiento o profilaxis de trastornos psicoticos, esquizofrenia, ansiedad, entre otras enfermedades. |